Widespread Natural Variation in Murine Natural Killer T-cell Number and Function

Overview

Journal Immunology

Specialty Allergy & Immunology

Date 2008 May 1

PMID 18445005

Citations 25

Authors

Stacia L Rymarchyk

Hayden Lowenstein

Jana Mayette

Samantha R Foster

David E Damby

Isaac W Howe

Idil Aktan

Russell E Meyer

Matthew E Poynter

Jonathan E Boyson

Affiliations

Soon will be listed here.

Abstract

Natural killer T (NKT) cells comprise a novel T-lymphocyte subset that can influence a wide variety of immune responses through their ability to secrete large amounts of a variety of cytokines. Although variation in NKT-cell number and function has been extensively studied in autoimmune disease-prone mice, in which it has been linked to disease susceptibility, relatively little is known of the natural variation of NKT-cell number and function among normal inbred mouse strains. Here, we demonstrate strain-dependent variation in the susceptibility of C57BL/6J and BALB/cJ mice to NKT-mediated airway hyperreactivity, which correlated with significant increases in serum interleukin-4 (IL-4) and IL-13 elicited by the synthetic glycosphingolipid alpha-galactosylceramide. Examination of NKT-cell function revealed a significantly greater frequency of cytokine-producing NKT cells in C57BL/6J versus BALB/cJ mice as well as significant differences in the kinetics of NKT-cell cytokine production. Extension of this analysis to a panel of inbred mouse strains indicated that variability in NKT-cell cytokine production was widespread. Similarly, an examination of NKT-cell frequency revealed a significantly greater number of liver NKT cells in the C57BL/6J mice versus BALB/cJ mouse livers. Again, examination of a panel of inbred mouse strains revealed that liver NKT-cell numbers were quite variable, spanning over a 100-fold range. Taken together, these results demonstrate the presence of widespread natural variation in NKT-cell number and function among common inbred mouse strains, which may have implications for the examination of the influence of NKT cells in immune responses and disease pathogenesis among different genetic backgrounds.

Citing Articles

SLAM Modification as an Immune-Modulatory Therapeutic Approach in Cancer.

Tojjari A, Giles F, Vilbert M, Saeed A, Cavalcante L Cancers (Basel). 2023; 15(19).

PMID: 37835502 PMC: 10571764. DOI: 10.3390/cancers15194808.

Glycolipid-peptide conjugate vaccines elicit CD8 T-cell responses and prevent breast cancer metastasis.

Burn O, Farrand K, Pritchard T, Draper S, Tang C, Mooney A Clin Transl Immunology. 2022; 11(7):e1401.

PMID: 35795321 PMC: 9250805. DOI: 10.1002/cti2.1401.

Development of αβ T Cells with Innate Functions.

Alberola-Ila J Adv Exp Med Biol. 2022; 1365:149-160.

PMID: 35567746 DOI: 10.1007/978-981-16-8387-9_10.

Modulation of Immune Responses to Influenza A Virus Vaccines by Natural Killer T Cells.

Driver J, de Carvalho Madrid D, Gu W, Artiaga B, Richt J Front Immunol. 2020; 11:2172.

PMID: 33193296 PMC: 7606973. DOI: 10.3389/fimmu.2020.02172.

Insights Into Mucosal-Associated Invariant T Cell Biology From Studies of Invariant Natural Killer T Cells.

Garner L, Klenerman P, Provine N Front Immunol. 2018; 9:1478.

PMID: 30013556 PMC: 6036249. DOI: 10.3389/fimmu.2018.01478.

References

Galli G, Nuti S, Tavarini S, Galli-Stampino L, De Lalla C, Casorati G . Innate immune responses support adaptive immunity: NKT cells induce B cell activation. Vaccine. 2003; 21 Suppl 2:S48-54. DOI: 10.1016/s0264-410x(03)00200-7. View

van den Elzen P, Garg S, Leon L, Brigl M, Leadbetter E, Gumperz J . Apolipoprotein-mediated pathways of lipid antigen presentation. Nature. 2005; 437(7060):906-10. DOI: 10.1038/nature04001. View

Wilson S, Kent S, Horton H, Hill A, Bollyky P, Hafler D . Multiple differences in gene expression in regulatory Valpha 24Jalpha Q T cells from identical twins discordant for type I diabetes. Proc Natl Acad Sci U S A. 2000; 97(13):7411-6. PMC: 16559. DOI: 10.1073/pnas.120161297. View

Mattner J, DeBord K, Ismail N, Goff R, Cantu 3rd C, Zhou D . Exogenous and endogenous glycolipid antigens activate NKT cells during microbial infections. Nature. 2005; 434(7032):525-9. DOI: 10.1038/nature03408. View

Rocha-Campos A, Melki R, Zhu R, Deruytter N, Damotte D, Dy M . Genetic and functional analysis of the Nkt1 locus using congenic NOD mice: improved Valpha14-NKT cell performance but failure to protect against type 1 diabetes. Diabetes. 2006; 55(4):1163-70. DOI: 10.2337/diabetes.55.04.06.db05-0908. View

Sriram V, Du W, Gervay-Hague J, Brutkiewicz R . Cell wall glycosphingolipids of Sphingomonas paucimobilis are CD1d-specific ligands for NKT cells. Eur J Immunol. 2005; 35(6):1692-701. DOI: 10.1002/eji.200526157. View

Hammond K, Poulton L, Palmisano L, Silveira P, Godfrey D, Baxter A . alpha/beta-T cell receptor (TCR)+CD4-CD8- (NKT) thymocytes prevent insulin-dependent diabetes mellitus in nonobese diabetic (NOD)/Lt mice by the influence of interleukin (IL)-4 and/or IL-10. J Exp Med. 1998; 187(7):1047-56. PMC: 2212199. DOI: 10.1084/jem.187.7.1047. View

Stanic A, Dharshan de Silva A, Park J, Sriram V, Ichikawa S, Hirabyashi Y . Defective presentation of the CD1d1-restricted natural Va14Ja18 NKT lymphocyte antigen caused by beta-D-glucosylceramide synthase deficiency. Proc Natl Acad Sci U S A. 2003; 100(4):1849-54. PMC: 149922. DOI: 10.1073/pnas.0430327100. View

Hong S, Wilson M, Serizawa I, Wu L, Singh N, Naidenko O . The natural killer T-cell ligand alpha-galactosylceramide prevents autoimmune diabetes in non-obese diabetic mice. Nat Med. 2001; 7(9):1052-6. DOI: 10.1038/nm0901-1052. View

10.

Biburger M, Tiegs G . Alpha-galactosylceramide-induced liver injury in mice is mediated by TNF-alpha but independent of Kupffer cells. J Immunol. 2005; 175(3):1540-50. DOI: 10.4049/jimmunol.175.3.1540. View

11.

Eberl G, MacDonald H . Selective induction of NK cell proliferation and cytotoxicity by activated NKT cells. Eur J Immunol. 2000; 30(4):985-92. DOI: 10.1002/(SICI)1521-4141(200004)30:4<985::AID-IMMU985>3.0.CO;2-E. View

12.

Griewank K, Borowski C, Rietdijk S, Wang N, Julien A, Wei D . Homotypic interactions mediated by Slamf1 and Slamf6 receptors control NKT cell lineage development. Immunity. 2007; 27(5):751-62. PMC: 2170879. DOI: 10.1016/j.immuni.2007.08.020. View

13.

Hayakawa Y, Takeda K, Yagita H, Van Kaer L, Saiki I, Okumura K . Differential regulation of Th1 and Th2 functions of NKT cells by CD28 and CD40 costimulatory pathways. J Immunol. 2001; 166(10):6012-8. DOI: 10.4049/jimmunol.166.10.6012. View

14.

Naumov Y, Bahjat K, Gausling R, Abraham R, Exley M, Koezuka Y . Activation of CD1d-restricted T cells protects NOD mice from developing diabetes by regulating dendritic cell subsets. Proc Natl Acad Sci U S A. 2001; 98(24):13838-43. PMC: 61128. DOI: 10.1073/pnas.251531798. View

15.

Chen Y, Driver J, Silveira P, Serreze D . Subcongenic analysis of genetic basis for impaired development of invariant NKT cells in NOD mice. Immunogenetics. 2007; 59(9):705-12. DOI: 10.1007/s00251-007-0236-4. View

16.

Stein-Streilein J, Sonoda K, Faunce D . Regulation of adaptive immune responses by innate cells expressing NK markers and antigen-transporting macrophages. J Leukoc Biol. 2000; 67(4):488-94. DOI: 10.1002/jlb.67.4.488. View

17.

Singh A, Wilson M, Hong S, Olivares-Villagomez D, Du C, Stanic A . Natural killer T cell activation protects mice against experimental autoimmune encephalomyelitis. J Exp Med. 2001; 194(12):1801-11. PMC: 2193577. DOI: 10.1084/jem.194.12.1801. View

18.

Jordan M, Fletcher J, Baxter A . Genetic control of NKT cell numbers. Immunol Cell Biol. 2004; 82(3):276-84. DOI: 10.1111/j.0818-9641.2004.01264.x. View

19.

Poulton L, Smyth M, Hawke C, Silveira P, Shepherd D, Naidenko O . Cytometric and functional analyses of NK and NKT cell deficiencies in NOD mice. Int Immunol. 2001; 13(7):887-96. DOI: 10.1093/intimm/13.7.887. View

20.

Grunig G, Warnock M, Wakil A, Venkayya R, Brombacher F, Rennick D . Requirement for IL-13 independently of IL-4 in experimental asthma. Science. 1998; 282(5397):2261-3. PMC: 3897229. DOI: 10.1126/science.282.5397.2261. View